KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $40,000 | -80.7% | 893 | -75.9% | 0.01% | -83.0% |
| Q3 2016 | $207,000 | +20.3% | 3,700 | +7.8% | 0.05% | -8.6% |
| Q2 2016 | $172,000 | +21.1% | 3,431 | +11.3% | 0.06% | +87.1% |
| Q1 2016 | $142,000 | -29.0% | 3,083 | -5.0% | 0.03% | +3.3% |
| Q4 2015 | $200,000 | +308.2% | 3,244 | +270.7% | 0.03% | +233.3% |
| Q3 2015 | $49,000 | +308.3% | 875 | +333.2% | 0.01% | +200.0% |
| Q4 2014 | $12,000 | – | 202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |